Shares of Scilex Holding (NASDAQ:SCLXW – Get Free Report) dropped 2.2% during mid-day trading on Thursday . The company traded as low as $0.1999 and last traded at $0.2030. Approximately 4,089 shares traded hands during trading, a decline of 28% from the average session volume of 5,690 shares. The stock had previously closed at $0.2075.
Scilex Stock Performance
The company has a 50 day moving average price of $0.16 and a 200 day moving average price of $0.14.
Scilex Company Profile
Scilex Holding Company is a specialty pharmaceutical firm focused on the commercialization, licensing and distribution of branded products for the management of acute and chronic pain. Established through a series of strategic acquisitions and internal development efforts, the company concentrates on non-opioid, topical and systemic therapies designed to address unmet needs in neuropathic and musculoskeletal pain. Scilex partners with healthcare providers, pharmacies and specialty distributors to bring its portfolio to patients across the United States.
The company’s flagship product, ZTlido® (lidocaine topical system 1.8%), is an FDA-approved prescription patch indicated for the relief of pain associated with postherpetic neuralgia.
Featured Stories
- Five stocks we like better than Scilex
- PriceSmart Stock Eyes $220 as Chile Expansion Fuels Growth
- Dollar Tree’s Turnaround Is Starting to Take Root
- Why Levi’s Digital Strategy Is Paying Off in a Big Way
- Constellation Brands: Beer Growth and Buybacks Mask Stock’s Slump
Receive News & Ratings for Scilex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Scilex and related companies with MarketBeat.com's FREE daily email newsletter.
